Bettonte, Sara, Berton, Mattia and Marzolini, Catia 
ORCID: 0000-0002-2312-7050
(2022)
Magnitude of Drug-Drug Interactions in Special Populations.
Pharmaceutics, 14 (4).
p. 789.
Abstract
Drug-drug interactions (DDIs) are one of the most frequent causes of adverse drug reactions or loss of treatment efficacy. The risk of DDIs increases with polypharmacy and is therefore of particular concern in individuals likely to present comorbidities (i.e., elderly or obese individuals). These special populations, and the population of pregnant women, are characterized by physiological changes that can impact drug pharmacokinetics and consequently the magnitude of DDIs. This review compiles existing DDI studies in elderly, obese, and pregnant populations that include a control group without the condition of interest. The impact of physiological changes on the magnitude of DDIs was then analyzed by comparing the exposure of a medication in presence and absence of an interacting drug for the special population relative to the control population. Aging does not alter the magnitude of DDIs as the related physiological changes impact the victim and perpetrator drugs to a similar extent, regardless of their elimination pathway. Conversely, the magnitude of DDIs can be changed in obese individuals or pregnant women, as these conditions impact drugs to different extents depending on their metabolic pathway.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | drug interaction, elderly, obese, pregnant women, special populations |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Systems, Molecular and Integrative Biology |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 29 Feb 2024 09:20 |
| Last Modified: | 29 Feb 2024 09:20 |
| DOI: | 10.3390/pharmaceutics14040789 |
| Open Access URL: | https://doi.org/10.3390/pharmaceutics14040789 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3178991 |
Dimensions
Dimensions
